Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Income from Continuing Operations of 1186000.0 for Q1 2026, up 337.64% year-over-year from 271000.0 in Q1 2025, and down 66.24% quarter-over-quarter from 3513000.0 in Q4 2025.
Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Income from Continuing Operations for 17 consecutive years, with 1186000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 337.64% year-over-year to 1186000.0; the TTM figure through Mar 2026 stood at 10518000.0 (down 97.89% YoY), while the FY2025 annual figure was 12130000.0, down 38.08% from the prior year.
- Income from Continuing Operations retreated to 1186000.0 in Q1 2026 per BLFS's latest filing, from 3513000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 91004000.0 in Q4 2022 and bottomed at 72878000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 2105529.41 across 5 years, with a median of 3199000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 13159.49% — and 2025, when it soared 689.44%.
- Biolife Solutions' Income from Continuing Operations stood at 91004000.0 in 2022, then plunged by 80.35% to 17886000.0 in 2023, then sank by 97.51% to 445000.0 in 2024, then jumped by 689.44% to 3513000.0 in 2025, then sank by 66.24% to 1186000.0 in 2026.
- Business Quant data shows BLFS's Income from Continuing Operations at 1186000.0 in Q1 2026, 3513000.0 in Q4 2025, and 621000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 45.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.10 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | -15.84 Mn |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 445,000.00 |
| Sep 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -5.56 Mn |
| Mar 31, 2024 | -3.20 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | -15.80 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -13.71 Mn |
| Dec 31, 2022 | 91.00 Mn |
| Sep 30, 2022 | -10.32 Mn |
| Jun 30, 2022 | -72.88 Mn |
| Mar 31, 2022 | -7.42 Mn |
| Dec 31, 2021 | -15.75 Mn |
| Sep 30, 2021 | 79,000.00 |